Study summary

FK949E was administered to elderly bipolar disorder patients with major depressive episode for 52 weeks. Its safety, efficacy, and plasma concentration change were evaluated in an open-label manner.

Additional Study Details

Phase
3
Product
  • FK949E
  • Type
    Interventional
    Masking
    None (Open Label)
    Enrollment number
    20
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): Japanese

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for Long-term study of FK949E in elderly bipolar disorder patients? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site JP00030
      Tottori, Tottori, Japan
      Completed
      Site JP00013
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00019
      Kumamoto, Kumamoto, Japan
      Completed
      Site JP00018
      Kyoto, Kyoto, Japan
      Completed
      Site JP00012
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00021
      Tokyo, Tokyo, Japan
      Completed
      Site JP00023
      Fukuoka, Fukuoka, Japan
      Completed
      Site JP00010
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00007
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00008
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00004
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00027
      Tokyo, Tokyo, Japan
      Completed
      Site JP00006
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00031
      Ibaraki, Ibaraki, Japan
      Completed
      Site JP00022
      Tokyo, Tokyo, Japan
      Completed
      Site JP00005
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00011
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00029
      Fukushima, Fukushima, Japan
      Completed
      Site JP00009
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00028
      Hyogo, Hyogo, Japan
      Completed
      Site JP00002
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00032
      Kanagawa, Kanagawa, Japan
      Completed
      Site JP00003
      Hokkaido, Hokkaido, Japan
      Completed
      Site JP00020
      Tokyo, Tokyo, Japan
      Completed
      Site JP00014
      Osaka, Osaka, Japan
      Completed
      Site JP00016
      Tokyo, Tokyo, Japan
      Completed
      Site JP00026
      Tokyo, Tokyo, Japan
      Completed
      Site JP00017
      Kanagawa, Kanagawa, Japan
      Completed
      Site JP00024
      Chiba, Chiba, Japan
      Completed
      Site JP00015
      Fukushima, Fukushima, Japan
      Completed
      Site JP00025
      Fukuoka, Fukuoka, Japan
      Completed
      Site JP00001
      Hokkaido, Hokkaido, Japan

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?